Dental Biomaterials Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, Metal-Ceramic Biomaterials, Natural Biomaterials, Composites Biomaterials), By Application (Orthodontics, Implantology, Prosthodontics, Others), By End User (Dental Hospitals& Clinics, Dental laboratories, Dental Academies and Research Institutes, Dental Product manufacturers), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 8.53 Billion
CAGR (2026-2031)	6.13%
Fastest Growing Segment	Ceramic Biomaterials
Largest Market	North America
Market Size (2031)	USD 12.19 Billion

Market Overview

The Global Dental Biomaterials Market will grow from USD 8.53 Billion in 2025 to USD 12.19 Billion by 2031 at a 6.13% CAGR. Dental biomaterials encompass a range of biocompatible synthetic and natural substances engineered to repair damaged dental structures, replace missing teeth, or regenerate oral tissues. The market is primarily driven by an aging global population necessitating restorative care and a rising incidence of periodontal disorders. Additionally, the growing consumer demand for aesthetic dental improvements and cosmetic procedures provides a robust foundation for continuous industry expansion, distinguishing these fundamental drivers from transient technological shifts.

Conversely, the high cost of advanced dental treatments and inadequate reimbursement coverage in emerging economies present a significant challenge that could impede broader market adoption. This financial constraint limits accessibility for a substantial patient demographic. According to the American Dental Association, in 2025, consumer dental spending in the United States increased by 4% as of August compared to the start of the year, highlighting the sector's resilience and the sustained demand for material-intensive dental services despite economic pressures.

Key Market Drivers

The growing penetration of dental implants and restorative solutions serves as a critical engine for the sector, significantly increasing the consumption of bone grafts, barrier membranes, and osseointegrative substances. As patients increasingly prioritize fixed prosthetic solutions over removable dentures, the requirement for advanced biocompatible materials that ensure long-term stability has surged. This trend is evidenced by the operational scale of major industry players who are witnessing higher patient throughput for replacement therapies. According to Straumann Group, February 2025, in the 'Annual Report 2024', the organization helped 6.7 million smiles in 2024, an increase of 1.1 million patients compared to the previous year. This expansion in patient volume directly correlates with intensified demand for the synthetic and xenogeneic substitutes used in ridge augmentation and socket preservation procedures.

Simultaneously, the rising incidence of dental caries and periodontal diseases necessitates a sustained volume of interventions, maintaining demand for restorative composites, cements, and regeneration agents. As healthcare infrastructure recovers and patient access improves, the sheer frequency of treatments drives substantial material utilization. According to the NHS Business Services Authority, August 2025, in the 'NHS Dental Statistics – England 2024-25' report, 35 million courses of treatment were delivered during the 2024-25 financial year, marking a 4% increase from the previous period. This rebound in activity supports the financial performance of material manufacturers, reflecting a resilient market environment. According to Envista Holdings Corporation, in 2025, the company achieved third-quarter sales of $670 million with a core sales growth of 9.4% year-over-year, illustrating the robust capitalization on these persistent restorative care demands.

Download Free Sample Report

Key Market Challenges

The high cost of advanced dental treatments creates a severe economic barrier that restricts the widespread adoption of premium dental biomaterials. When the acquisition price of synthetic bone grafts, membranes, and restorative composites rises, the operational overhead for dental practices increases disproportionately. If reimbursement rates from insurance providers or state healthcare systems do not adjust to match these rising input costs, dental professionals are financially disincentivized from utilizing top-tier biomaterials. This price sensitivity forces practitioners to either absorb the financial deficit or opt for less expensive, lower-quality alternatives, effectively capping the volume of advanced materials sold and limiting market penetration to only the most affluent patient demographics.

This financial strain is exacerbated by inflationary pressures on the supply chain, which directly erode the profit margins required to sustain a material-intensive industry. As procurement costs climb, the gap between the expense of delivering care and the available funding widens, causing a stagnation in inventory turnover. According to the American Dental Association, in 2025, the majority of surveyed dental practices reported that prices for equipment and supplies had increased by more than 5% since the beginning of the year. This measurable rise in material costs, without a commensurate increase in reimbursement, directly hampers the growth of the Global Dental Biomaterials Market by reducing the purchasing power of the primary end-users.

Key Market Trends

The expansion of digital and 3D-printable material portfolios is fundamentally altering clinical workflows by enabling the direct fabrication of complex appliances with unprecedented precision. This trend is characterized by the increasing adoption of specialized biocompatible resins and thermoplastics that function seamlessly within CAD/CAM ecosystems, effectively replacing traditional analog impression materials. As dental professionals prioritize efficiency, the consumption of these digitally optimized materials for clear aligners and printed prosthetics has accelerated, driving manufacturers to broaden their formulations. According to Align Technology, October 2025, in the 'Q3 2025 Financial Results', clear aligner volume increased by 4.9% year-over-year to 647.8 thousand cases, demonstrating the sustained industrial scale of digital material utilization in orthodontic treatments.

Simultaneously, there is a surge in demand for high-translucency zirconia and all-ceramic solutions, driven by the patient requirement for superior esthetics and metal-free restorations. This market shift is accelerating the obsolescence of porcelain-fused-to-metal frameworks in favor of monolithic materials that combine high fracture toughness with natural optical properties. The integration of intraoral scanners further catalyzes this transition, as digital impressions seamlessly interface with milling units to produce these ceramic restorations at high velocity. According to Modern Dental Group, August 2025, in the 'Interim Report 2025', the volume of digital solution cases produced at its major facilities increased by 24.4% year-over-year to approximately 457,653 units, reflecting the dominant market preference for millable ceramic systems.

Segmental Insights

The Ceramic Biomaterials segment represents the fastest-growing category within the Global Dental Biomaterials Market, driven significantly by escalating patient demand for superior aesthetic outcomes. These materials, particularly zirconia and glass-ceramics, are increasingly favored for their exceptional translucency and ability to blend seamlessly with natural dentition. Additionally, the integration of digital dentistry allows for the efficient milling of high-strength ceramic restorations. Continuous product clearances by major regulatory entities, such as the U.S. Food and Drug Administration, confirm the biocompatibility and durability of these solutions, thereby reinforcing their preference among practitioners for restorative procedures.

Regional Insights

North America holds a dominant position in the dental biomaterials market due to well-established healthcare infrastructure and high expenditure on oral care. The region benefits from a strong concentration of key industry players and continuous research initiatives supported by institutions like the National Institute of Dental and Craniofacial Research. Additionally, the U.S. Food and Drug Administration provides clear regulatory frameworks that facilitate product approvals and safety compliance. Rising demand for restorative procedures among the aging population and the widespread availability of dental insurance plans further sustain this regional leadership.

Recent Developments

• In December 2025, RevBio, Inc. received approval from the U.S. Food and Drug Administration to initiate a pilot clinical trial for its novel regenerative bone adhesive, Tetranite, in dental applications. The study is designed to evaluate the safety and efficacy of the biomaterial in dental ridge augmentation procedures without the use of ancillary containment devices like membranes or screws. This regulatory milestone marks a key advancement in the research of adhesive biomaterials that can stabilize bone graft materials and potentially accelerate healing times for patients requiring dental implants, offering a streamlined alternative to traditional bone grafting techniques.
• In July 2024, TBS Dental entered the regenerative market with the launch of a new comprehensive line of biomaterials branded as REGEN. This new product suite includes a variety of bone grafting materials and barrier membranes designed to aid in socket preservation and soft tissue regeneration. The launch features user-friendly delivery systems, such as ergonomic syringes for mineralized cortico-cancellous bone particulates, aiming to streamline surgical workflows. This expansion represents a significant strategic move for the company, broadening its focus from instruments to include essential biological materials for dental implantology and tissue repair.
• In April 2024, Geistlich Pharma AG finalized the acquisition of Bionnovation Biomedical, a Brazilian medical technology company specializing in regenerative dental products. This strategic collaboration expands the Swiss company's global footprint in the dental biomaterials market, particularly within Latin America and other emerging regions. By integrating the acquired entity's expertise in developing and manufacturing bone and tissue regeneration materials, the acquiring company aims to diversify its product offerings and provide clinicians with a broader range of reliable, high-quality solutions for regenerative dentistry procedures and implant site development.
• In January 2024, SprintRay Inc. announced the establishment of a specialized laboratory dedicated to the advancement of dental material science. The company unveiled its BioMaterial Innovation Lab, a facility designed to develop and test proprietary 3D printing resins and other dental biomaterials. Alongside this development, the company introduced a new portfolio of resins, including materials for full-arch fixed hybrid dentures and high-impact removable dentures. This strategic initiative aims to accelerate the creation of next-generation restorative materials, thereby enhancing the precision and efficiency of in-office digital dentistry workflows while addressing the growing demand for advanced 3D printing solutions.

Key Market Players

• Institut Straumann AG
• Geistlich Pharma AG
• Zimmer Biomet Holdings, Inc.
• Danaher Corporation
• Dentsply Sirona, Inc.
• 3M Company
• CRS Holdings, LLC.
• Medtronic PLC
• Henry Schein, Inc.
• Mitsui Chemicals, Inc.

By Type	By Application	By End User	By Region
Metallic Biomaterials Ceramic Biomaterials Polymeric Biomaterials Metal-Ceramic Biomaterials Natural Biomaterials Composites Biomaterials	Orthodontics Implantology Prosthodontics Others	Dental Hospitals& Clinics Dental laboratories Dental Academies and Research Institutes Dental Product manufacturers	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Dental Biomaterials Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Dental Biomaterials Market, By Type:

• Metallic Biomaterials
• Ceramic Biomaterials
• Polymeric Biomaterials
• Metal-Ceramic Biomaterials
• Natural Biomaterials
• Composites Biomaterials

• Dental Biomaterials Market, By Application:

• Orthodontics
• Implantology
• Prosthodontics
• Others

• Dental Biomaterials Market, By End User:

• Dental Hospitals& Clinics
• Dental laboratories
• Dental Academies and Research Institutes
• Dental Product manufacturers

• Dental Biomaterials Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE